DJIA 16,805.41 127.51 0.76%
NASDAQ 4,483.72 30.92 0.69%
S&P 500 1,964.58 13.76 0.71%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

5.13 0.14 (2.81%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $5.13 2.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.02
Previous Close $4.99
Daily Range $4.99 - $5.25
52-Week Range $2.68 - $6.95
Market Cap $1.2B
P/E Ratio -16.10
Dividend (Yield) $0.00 (0.0%)
Volume 5,751,537
Average Daily Volume 3,736,210
Current FY EPS -$0.30

Sector

Healthcare

Industry

Drugs

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary

Roundtable: 3 Stocks Janet Yellen Is Dead Wrong About

The Fed thinks biotech stocks are overvalued. Here's where they're wrong.

Novavax To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Su

Novavax To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26

Must See Charts: 4 Biotech Stocks to Watch in a Market Snapback

Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape

Novavax Breaks Above 200-Day Moving Average - Bullish for NVAX

Novavax Begins Mid-Stage Study on RSV Vaccine in Elders - Analyst Blog

Perilous Reversal Watch: Novavax (NVAX)

Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Ant

Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies

13 Analyst Stocks Under $10 With Major Upside Calls

Genocea Up on Positive GEN-003 Data for Genital Herpes - Analyst Blog

3 Biotech Stocks Under $10 in Breakout Territory

See More NVAX News...

NVAX's Top Competitors

NVAX $5.13 (2.81%)
Current stock: NVAX
AMGN $147.26 (0.01%)
Current stock: AMGN
GILD $110.71 (3.29%)
Current stock: GILD
BIIB $321.67 (1.77%)
Current stock: BIIB